Reuters logo
BRIEF-Valbiotis Announces Positive Preclinical Results For Totum-63
December 6, 2017 / 4:59 PM / 6 days ago

BRIEF-Valbiotis Announces Positive Preclinical Results For Totum-63

Dec 6 (Reuters) - VALBIOTIS SAS:

* VALBIOTIS ANNOUNCES POSITIVE PRECLINICAL RESULTS FOR TOTUM-63, THE ACTIVE INGREDIENT IN VAL-63-NAFLD, FOR NON-ALCOHOLIC FATTY LIVER (NAFL), A RISK FACTOR FOR NASH

* SHARP 40% REDUCTION IN HEPATIC TRIGLYCERIDES IN PRECLINICAL PHASE, IMPROVEMENT OF RELATED METABOLIC PARAMETERS

* CONFIRMATION OF POSITIVE DATA ALREADY OBTAINED IN DIABETIC MODELS Source text for Eikon: Further company coverage: (Gdynia Newsroom)

Our Standards:The Thomson Reuters Trust Principles.
0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below